nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 29th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
69.0
|
71.0
|
59.0
|
62.0
|
61.0
|
65.0
|
59.0
|
65.0
|
62.0
|
66.0
|
64.0
|
83.0
|
138.00
|
138.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 29th, 2022 12:19PM
|
Aug 29th, 2022 12:19PM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 28th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
66.0
|
70.0
|
72.0
|
59.0
|
63.0
|
62.0
|
65.0
|
60.0
|
65.0
|
63.0
|
66.0
|
64.0
|
82.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 28th, 2022 05:18AM
|
Aug 28th, 2022 05:18AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 27th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
66.0
|
70.0
|
72.0
|
59.0
|
63.0
|
62.0
|
65.0
|
60.0
|
65.0
|
63.0
|
66.0
|
64.0
|
82.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 27th, 2022 04:38AM
|
Aug 27th, 2022 04:38AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 25th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
66.0
|
70.0
|
72.0
|
59.0
|
63.0
|
62.0
|
65.0
|
60.0
|
65.0
|
63.0
|
66.0
|
64.0
|
82.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 25th, 2022 09:17AM
|
Aug 25th, 2022 09:17AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 23rd, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
66.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
81.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 23rd, 2022 11:10AM
|
Aug 23rd, 2022 11:10AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 21st, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
80.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 21st, 2022 12:54PM
|
Aug 21st, 2022 12:54PM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 20th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
80.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 20th, 2022 02:32PM
|
Aug 20th, 2022 02:32PM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 19th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
80.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 19th, 2022 12:54PM
|
Aug 19th, 2022 12:54PM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 18th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
80.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 18th, 2022 04:38AM
|
Aug 18th, 2022 04:38AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:mygn
|
https://www.indeed.com/cmp/myriad-genetics,-inc.
|
Aug 17th, 2022 12:00AM
|
Open
|
Myriad Genetics
|
|
Healthcare
|
At Myriad, our goal is to make a difference in patients’ lives and our work has been guided by this mission throughout the Company’s history.
Myriad is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. More than 1.5 million patients have already benefited from Myriad’s hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care.
Today, Myriad continues this strong tradition. We are expanding our reach and increasing our impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Mission: At Myriad, we have four core values that continuously guide our work.
Passionate About Patients worldwide and transforming
their lives with the Pioneering Spirit to lead a revolution in healthcare through breakthrough discoveries, acting as Trusted Advisers to patients and physicians earned by a relentless pursuit of perfection and professional integrity as part of a United Team born out of the utmost respect for each other and a singular outward focus on patient care.
|
RRv1_500M_1B
|
Salt Lake City, UT
|
|
|
|
3.50
|
62.0
|
65.0
|
71.0
|
72.0
|
60.0
|
63.0
|
62.0
|
66.0
|
60.0
|
66.0
|
63.0
|
67.0
|
64.0
|
80.0
|
137.00
|
137.00
|
3.30
|
3.60
|
3.10
|
3.00
|
3.60
|
27.00
|
About two weeks
|
28.00
|
MEDIUM
|
29.00
|
AVERAGE
|
|
|
|
Aug 17th, 2022 10:17AM
|
Aug 17th, 2022 10:17AM
|
Myriad Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|